Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15Head & Neck 11Gynecologic 8Genitourinary 4Thoracic 3Breast 2Lymphoid 1Classical hematology 1CNS 1

Conditions

Anemia, Refractory, with Excess of Blasts 32Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 21Leukemia, Myelomonocytic, Chronic 18Lymphoma, Non-Hodgkin 17Myeloproliferative Disorders 15Thrombocytopenia 13Anemia, Aplastic 13Anemia 12Hodgkin Disease 11Hematologic Neoplasms 11Multiple Myeloma 10Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 9Anemia, Refractory 9Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Fanconi Anemia 7Congenital Abnormalities 7Blast Crisis 7Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6Cytopenia 6Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Primary Immunodeficiency Diseases 4

Interventions

SRA737 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Anus Neoplasms × Classical hematology × Clear all
NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡